OliX Pharmaceuticals...
KOSDAQ:A226950
156.500,00
₩-800,00 (-0,51%)
156.500,00
₩-800,00 (-0,51%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩-800,00
Earnings Per Share
₩794,52
Revenue Per Share
0,00%
Gross Margin %
₩3.175,87 B
Market Cap
₩21,43 B
Long-Term Debt
Earnings Per Share
₩-800,00
Revenue Per Share
₩794,52
Gross Margin %
0,00%
Market Cap
₩3.175,87 B
Long-Term Debt
₩21,43 B

Financials

Year Year 2025 2024
EPS Earnings Per Share ₩-800,00 ₩-1.474,00
Earnings Earnings ₩-14,77B ₩-27,21B
RPS Revenue Per Share ₩794,52 ₩134,03
Revenue Revenue ₩14,67B ₩2,47B
OCF Operating Cash Flow ₩-31,00B ₩-3,76B
FCF Free Cash Flow ₩0,00M ₩0,00M
OM Operating Margin 0,00% 0,00%
GM % Gross Margin % 0,00% 95,62%
FCFS Free Cash Flow Per Share ₩0,00 ₩-2.474,61
LT Debt Long-Term Debt ₩21,43B ₩21,43B
Sha. Stocks 18,46M 18,46M
×